SM
PGEN icon

Samantha McLemore’s Precigen PGEN Stock Holding History

Samantha McLemore’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-450,000
Closed -$950K – 44
2022
Q1 		$950K Buy
+450,000
New +$1.1M 0.32% 43

Other funds holding PGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

Samantha McLemore's PGEN Position: Q2 2026 in Review

Samantha McLemore increased its Precigen (PGEN) stake by 6.8% in Q2 2026, buying an estimated $5.27M and bringing the position to 19,036,976 shares worth $109M. The position accounts for 3.56% of the portfolio, ranked #12.

Samantha McLemore first reported a position in PGEN in Q4 2021 and has held it in 19 quarters since. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Samantha McLemore held 19,036,976 shares of Precigen worth $109M as of Q2 2026.
  • Samantha McLemore bought 1,219,589 Precigen shares in Q2 2026, an estimated $5.27M.
  • Precigen made up 3.56% of Samantha McLemore's portfolio in Q2 2026, its #12 holding.
  • Samantha McLemore first reported a position in Precigen in Q4 2021 and has held it in 19 quarters since.
  • 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.